Retatrutide Treatment in Streptozotocin-Induced Diabetic Rats: Renal Inflammatory Cytokines, HIF‑1α Signalling, and Histopathological Injury Profile
This study demonstrates that while Retatrutide treatment in streptozotocin-induced diabetic rats significantly attenuates HIF-1α upregulation and shows a non-significant trend toward reducing renal inflammation and histopathological injury, it does not yet confer overt structural renoprotection, suggesting that longer durations or chronic disease models are needed to confirm its therapeutic potential.